Mittie Doyle, Chief Medical Officer at Avalo Therapeutics, sold AVTX on Jun 23, 2026
Prices as of Oct 16 · price update delayed · Every feed →
- Traded
- Jun 23, 2026
- Disclosed
- Jun 25, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
AVTX since disclosure
−37.4%
after the sale
Similar stocks (XLV) since disclosure
+13.5%
XLV — its sector index fund
Change in closing price from Jun 25, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.